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Problems associated with the abuse of amphetamine-type stimulants, including
methamphetamine (MA), pose serious health and socioeconomic issues world-wide.
While it is well-established that MA’s psychopharmacological effects involve interactions
with monoamine neurotransmission, accumulating evidence from animal models
implicates dysregulated glutamate in MA addiction vulnerability and use disorder.
Recently, we discovered an association between genetic vulnerability to MA-taking and
increased expression of the glutamate receptor scaffolding protein Homer2 within both
the shell and core subregions of the nucleus accumbens (NAC) and demonstrated a
necessary role for Homer2 within the shell subregion in MA reward and reinforcement in
mice. This report extends our earlier work by interrogating the functional relevance of
Homer2 within the NAC core for the conditioned rewarding and reinforcing properties of
MA. C57BL/6J mice with a virus-mediated knockdown of Homer2b expression within the
NAC core were first tested for the development and expression of a MA-induced
conditioned place-preference/CPP (four pairings of 2 mg/kg MA) and then were trained
to self-administer oral MA under operant-conditioning procedures (5–80 mg/L). Homer2b
knockdown in the NAC core augmented a MA-CPP and shifted the dose-response
function for MA-reinforced responding, above control levels. To determine whether
Homer2b within NAC subregions played an active role in regulating MA reward and
reinforcement, we characterized the MA phenotype of constitutive Homer2 knockout (KO)
mice and then assayed the effects of virus-mediated overexpression of Homer2b within
the NAC shell and core of wild-type and KO mice. In line with the results of NAC core
knockdown, Homer2 deletion potentiated MA-induced CPP, MA-reinforced responding
and intake, as well as both cue- and MA-primed reinstatement of MA-seeking followingg February 2020 | Volume 11 | Article 111
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Frontiers in Psychiatry | www.frontiersin.orgextinction. However, there was no effect of Homer2b overexpression within the NAC core
or the shell on the KO phenotype. These data provide new evidence indicating a globally
suppressive role for Homer2 in MA-seeking and MA-taking but argue against specific
NAC subregions as the neural loci through which Homer2 actively regulates MA
addiction-related behaviors.Keywords: Homer2, place-preference, self-administration, nucleus accumbens, adeno-associated virus,
knock-outINTRODUCTION
Amphetamine-type stimulants, including methamphetamine
(MA), are the most highly abused psychostimulants in the
world, with an estimated 29 million users worldwide in 2017
(1) . Despite the prevalence and severity of MA Use Disorder, the
lack of knowledge regarding the neurobiological substrates
underlying risk, development and severity impedes therapeutic
progress. MA reinforcement and psychomotor activation
involves monoamine release and reuptake inhibition,
particularly within dopaminergic neurons from the ventral
tegmental area (VTA) to the nucleus accumbens (NAC) (2).,
Accumulating evidence supports the role of glutamate
transmission, especially glutamatergic projections from the
prefrontal cortex (PFC) to the NAC, in both MA addiction
vulnerability and the long-term neuroplasticity maintaining the
MA-addicted state (3–6).
It has been known for decades that binge-like, high-dose (> 4
mg/kg) MA exposure induces glutamate-dependent
neurotoxicity within the dorsal striatum (7). However,
subchronic administration of subtoxic MA doses (< 2 mg/kg)
can also elevate extracellular glutamate within the NAC (3, 8). In
addition, such exposure is sufficient to increase the expression/
function of mGlu1/5 glutamate receptors and their associated
scaffolding protein Homer2 within this region (8). Indeed, a
survey of the extant literature on animal models of MA abuse
supports a correlative link between potentiated indices of
glutamate signaling and addiction-related behavior, including
self-administration, MA-induced reinstatement of drug-seeking
after abstinence or extinction, incubation of MA-craving, and
conditioned place-preference (CPP) (8–17).
Supporting a link between NAC glutamate and MA addiction
vulnerability, drug-naïve mice selectively bred for high MA
intake (MAHDR) exhibit several glutamate anomalies within
the NAC, relative to MALDR mice selectively bred for low MA
drinking (18–22). These differences include elevated basal and
MA-induced increases in extracellular glutamate, increased
expression of Homer2 and mGlu5, and decreased expression of
the EAAT3 glutamate transporter responsible for clearing
synaptic glutamate (3, 8). Further, NMDA glutamate receptor
antagonists attenuate MA-conditioned reward and behavioral
sensitization (14), while pharmacological manipulations of
extracellular glutamate in the NAC bidirectionally regulate the
expression of MA-conditioned reward in B6 mice (8). These
results provide causal evidence for a relationship between
glutamate and MA-induced behavior. Finally, small hairpin2RNA (shRNA)-mediated knockdown of Homer2 expression in
the shell subregion of the NAC reduces the magnitude of both a
MA CPP and oral MA intake during operant-conditioning
procedures (8), indicating for the first time a causal role for
Homer2, at least within the NAC shell, in regulating the
rewarding and reinforcing properties of MA.
The present study sought to extend our earlier results in the
NAC shell (8) to the NAC core subregion and to probe the
bidirectionality of the effects of transgenic manipulations of NAC
Homer2 expression on MA addiction-related behaviors. The
core and shell subregions of the NAC have distinct functions,
connectivity, and pharmacology that are still being characterized
within the context of addiction (23). Current theories argue that
the NAC core is embedded within subcircuits involved in
decision-making by signaling the motivational value of
expected goals to guide drug-seeking in drug-experienced
animals. In contrast, the NAC shell appears to be more
involved in the initial affective valence of the drug during early
drug experience (23). As Homer2 expression within both
subregions is correlated with MA addiction vulnerability in
mouse models (8), we first examined the effects of knocking
down Homer2 expression in the NAC core on MA-induced CPP
and the acquisition of oral MA self-administration in inbred
C57BL/6J (B6) mice. The combined results of our knockdown
studies suggest opposing roles for Homer2 within the NAC shell
and core in regulating MA reward and reinforcement. To
determine whether Homer2 contributes to the development of
MA CPP and oral intake, we also determined the effects of
upregulating Homer2 expression in both NAC subregions on the
behavior expressed by constitutive Homer2 knockout (KO) mice
and their wild-type (WT) counterparts.MATERIALS AND METHODS
Subjects
The knockdown studies employed adult, male C57BL/6J (B6)
mice (~8 weeks of age; The Jackson Laboratory, Sacramento,
CA). The remaining studies used both male and female adult (6–
8 weeks of age) Homer2 KO and wild-type (WT; on a mixed
129X1/svJ X C57BL/6J background) mice [see (24)] that were
bred in-house from the mating of heterozygous breeder pairs in
the Psychological and Brain Sciences vivarium at UCSB. Animals
were housed in groups of 3–5 mice in standard ventilated
polycarbonate cages, under standard, reverse-light, housingFebruary 2020 | Volume 11 | Article 11
Brown et al. Homer2 and Methampehtamineconditions in an AAALAC-accredited vivarium (lights on/off:
2200/1000 h), with ad libitum access to food and water. All
behavioral procedures were conducted during the dark phase of
the circadian cycle. All procedures were consistent with NIH
guidelines and approved by the Institutional Animal Care and
Use Committee of UCSB.
General Experimental Design
Homer2 within the NAC regulates both cocaine- (25) and
alcohol-induced (26–30) changes in behavior in murine
models, but the subregional specificity of Homer2’s role in
MA-related behavior has received relatively little experimental
attention (8). Thus, two experiments were conducted to further
address the role for NAC Homer2 expression in gating the
rewarding and reinforcing properties of MA. The first
experiment in this report sought to extend the results of a
prior study of the NAC shell (8) to the NAC core by
determining whether or not Homer2 expression within the
NAC core is necessary for MA reward/reinforcement. To
accomplish this, the first experiment in this report employed a
similar experimental design and approach as that described in
our previous report (8), which involved knocking down
Homer2b expression in the NAC core of B6 mice using an
adeno-associated viral vector (AAV) carrying a small hairpin
RNA (shRNA) against Homer2b. Control animals were infused
with an AAV carrying green fluorescent protein (GFP). The
details of the AAV-shRNA construct and the control AAV are
provided in Klugmann and Szumlinski (31) and Cozzoli etal.
(29) and the details of the specific procedures employed in this
shRNA study are provided in the subsections below. A time-line
of the procedures is provided in Figure 1A.
Combined, the results of our prior shRNA study of the NAC
shell (8) and those of the present study of the NAC core (see
Results below) argued that Homer2 expression within the NAC
shell and core plays opposing roles in gating MA reward/
reinforcement, with Homer2 in the shell promoting, and Homer2
in the core, suppressing MA addiction-related behaviors. Thus, a
follow-up experiment was conducted to determine whether or not
mimicking a MA-induced increase in Homer2 expression within
the NAC shell and core (8) would be sufficient to respectively
promote and suppress MA-induced place- and operant-
conditioning. To address this question, we employed an AAV
Homer2b-cDNA strategy similar to that used in previous studies
from our laboratory (25, 26, 32). As in our earlier work [e.g., (25)],
we infused aHomer2b AAV-cDNA construct [see (25) and (31) for
details of the cDNA construct] into the NAC shell or core of
Homer2 WT and constitutive KO mice, the latter of which enabled
determination of an active role for Homer2 within each subregion
in gating behavior. As the effects of constitutive Homer2 deletion
upon MA addiction-related behaviors had yet to be characterized,
we first compared the MA place- and operant-conditioning
phenotypes of Homer2 KO and WT mice on a mixed B6-129
hybrid genetic background. Then, we replicated the experiment in a
second cohort of Homer2 KO and WT mice infused with either the
AAV-cDNA or -GFP control. A time-line of procedures is
presented in Figure 5A.Frontiers in Psychiatry | www.frontiersin.org 3Surgeries and AAV Infusion
The surgical procedures to infuse the AAVs carrying either
shRNA-Homer2b, cDNA-Homer2b, or cDNA-GFP were
consistent with those previously described by our laboratory
(8, 29, 33). For B6 mice, we used the following stereotaxic
coordinates from Bregma (in mm): for core, AP: +1.3; ML: ±
1; DV: −4.3; for shell, AP: +1.3; ML: ± 0.5; DV: −4.8. Based on
our experience conducting craniotomies on B6-129 hybrid mice
[e.g., (25, 29, 33)], the following stereotaxic coordinates were
used for Homer2 KO and WT mice: for core, AP: +1.4; ML: ± 1;
DV: −4.3; for shell, AP: +1.4; ML: ± 0.5; DV: −4.6. Mice were
anesthetized with 1.5% isoflurane and positioned on the
stereotaxic apparatus. Thirty gauge microinjectors (12 mm)
were lowered bilaterally, directly into the core or shell. AAVs
were infused at a rate of 0.10 µl/min for 5 min (total volume/
side = 0.50 µl), and injectors were left in place for an additional 5
min prior to closing the incision site with tissue adhesive. The
shRNA and cDNA infusions procedures have been
demonstrated previously to reduce and increase, respectively,
Homer2b protein expression in mouse brain by approximately
50% (31, 33, 34). Animals were left in their home cages for a
minimum of 3 weeks prior to behavioral testing to allow for
maximal neuronal transduction (31).
Place-Conditioning and Locomotor Activity
MA place-conditioning procedures also followed those
previously employed by our laboratory (8) and included three
main phases: habituation/preconditioning test (day 1), MA/
saline (SAL) conditioning (days 2–9), and a postconditioning
test (day 10, post-test). The apparatus consisted of two distinct
compartments—one with black and white marble-patterned
walls and a textured floor, and the other with wood-patterned
walls and a smooth Plexiglas floor. During the habituation and
post-test sessions, mice were allowed free-access to both
compartments for 15 min via a divider with a door. During
conditioning, mice received 2 mg/kg MA intraperitoneal (IP)
injections and were immediately confined to one of the
compartments. On alternating days, mice were injected with an
equivalent volume of SAL (10 ml/kg) and confined to the other
compartment. Each conditioning session was 15 min in duration
and mice received four conditioning sessions for each
unconditioned stimulus. Overall, mice did not exhibit a strong
preference for one compartment vs. the other during the
habituation session, so the time spent on the SAL-paired side
during the post-test was subtracted from the time spent on the
MA-paired side to calculate a CPP score (8, 35). This CPP score
served to index the direction and magnitude of the MA-
conditioned reward. During each 15-min session, the
locomotor activity of the animals was recorded by digital video
cameras, interfaced with a PC-type computer equipped with
ANY-Maze software (Stoelting), recorded the distance traveled
(in m) during each of the sessions. As in our prior studies [e.g.,
(8)], MA-induced locomotor sensitization was measured by
subtracting the distance travelled during the first 15-min MA-
conditioning session from that on the fourth/last MA-
conditioning session.February 2020 | Volume 11 | Article 11
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In our prior study of the effects of Hoemr2 knock-down in the
NAC shell (8), the generalization of a place-conditioning
phenotype to operant-conditioning for MA reinforcement was
determined using a within-subjects design. To the best of our
knowledge, a parametric analysis of the effects of prior
behaviorally non-contingent MA upon subsequent drug-taking
has not been performed. Thus, we cannot speak to any potential
effects our place-conditioning procedures might have upon the
MA self-administration of the mice. However, we do know from
our prior study of B6 mice, that a mere history of non-contingent
MA treatment (four injections of 2 mg/kg MA, as employed in
the present study) does not necessarily promote subsequent MA
reinforcement/intake as MA-injected mice self-segregate into
high versus low MA-taking phenotypes when allowed to orally
self-administer the drug (8). To be consistent with our prior
study (8), following place-conditioning procedures, mice were
trained in daily 1-h sessions to nose-poke for delivery of
unadulterated MA solutions (prepared in tap water; reinforcerFrontiers in Psychiatry | www.frontiersin.org 4volume = 20 µl). Standard mouse operant-conditioning
chambers (MedAssociates, St Albans, VT, USA) were used to
measure instrumental responding for MA. Operant chambers
were fitted with two nose-poke holes, with a liquid receptacle
located in-between and chambers were housed in ventilated,
sound-attenuated chambers. Responses in the active (MA-
associated) hole resulted in the activation of the infusion
pump, delivery of 20 µl MA into the receptacle, and the
presentation of a 20-s light/tone compound stimulus. During
the 20-s MA-delivery period, further responding in the active
hole was recorded but had no programmed consequences.
Throughout the session, responding in the inactive hole had
no programmed consequences but was recorded to assess the
selectivity of responding in order to determine reinforcer
efficacy. Mice were first trained for 7 days to nose-poke for
delivery of a 10-mg/L MA solution under an FR1 schedule of
reinforcement. Animals that did not reach the acquisition criteria
of at least 10 active nose-pokes during the 1-h session, with
greater than 65% of their total nose-pokes directed at the activeFIGURE 1 | Homer2b knockdown in the nucleus accumbens (NAC) core potentiates a methamphetamine (MA)-induced CPP. (A) The procedural timeline for the
study examining the effects of shRNA-mediated knock-down of Homer2b within the NAC core. Representative micrographs of the neuronal transduction within the
NAC core by green fluorescent protein (GFP)-tagged adeno-associated viral vector (AAV)-shRNA against Homer2b at 10 X magnification (B) and 40 X magnification
(B’). AC, anterior commissure. (C) shRNA infusion potentiated MA-induced place conditioning, without altering the magnitude of locomotor sensitization that
developed during conditioning (D). The data represent the means ± SEMs of the number of mice indicated in Panel B. *p < 0.05 vs. GFP.February 2020 | Volume 11 | Article 11
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mice were excluded from the shRNA study and 20/114 mice were
excluded from the cDNA studies. As in our prior study of the
NAC shell (8), we next progressively increased the number of
nose-pokes required for delivery of the 10 mg/L MA reinforcer
(maintaining the 20-s time-out) over subsequent days (4–5 days/
schedule). We then conducted a dose-response study of MA
reinforcement and intake (5–80 mg/L) under the initial FR1 (20-s
time-out) reinforcement schedule (5 days/dose) as data indicated
an inverse relationship between MA intake and reinforcement
schedule (see Results). Given the inverse relationship between
operant-responding and reinforcement schedule, we opted to
forego this phase of testing in the cDNA study and animals
proceeded from training directly into dose-response testing. In
the operant-conditioning study of Homer2 WT and KO mice,
technical issues interfered with the testing of 13 of the 21 WT
mice at the 80 mg/L concentration. As such, the data from this
concentration were analyzed separately from the rest of the dose-
response function.
At the end of each 1-h operant session, the volume of solution
remaining in the receptacle was determined by pipetting. Mice
were returned to the colony room and left undisturbed until the
next day. Total MA intake was calculated each day by subtracting
the volume of MA remaining in the receptacle from the total
volume delivered to determine the total volume of MA
consumed. The volume consumed was converted into mg
consumed based on the concentration of the solution and then
amount of MA intake was expressed as a function of body weight
(in mg/kg), which was measured weekly (8).
Extinction and Reinstatement of the
Operant Response
In the cDNA study, the strength of the conditioned operant
response was established by repeatedly testing mice in daily
operant sessions in a MA-free state, with no light/tone stimulus,
until the number of active nose-pokes in a 1-hr session dropped
to 25% of initial MA-free responding (i.e., extinction). Animals
that did not reach these extinction criteria within 30 days were
excluded from the remainder of the study. Two additional mice
from the cDNA studies were excluded for failing to reach
extinction criteria. This extinction procedure was conducted
immediately upon the completion of dose-response testing (see
above). Following extinction, AAV-infused mice were then
subjected to a series of reinstatement of MA-seeking tests in
which responding in the active hole resulted in the presentation
of only the light/tone stimulus previously predictive of MA
delivery (i.e., MA reinforcement was withheld during
reinstatement testing). For reinstatement testing, mice were
administered a once-daily IP injection of 0.0 (SAL), 0.5 or 0.25
mg/kg MA, with doses increased across days, to examine the
degree of cue- andMA-induced reinstatement of the conditioned
response. Immediately following injection, mice were placed into
the operant-conditioning chamber for a period of 1 h, at which
time they were removed and returned to their home cages and
the number of active versus inactive nose-pokes were recorded.Frontiers in Psychiatry | www.frontiersin.org 5Histology
The goal of this study was to determine the subregional
specificity of the effects of AAV-mediated Homer2
manipulations within the NAC for MA addiction-related
behavior. As such, we deemed it important to determine the
neuroanatomical specificity of AAV infusion and thus, employed
immunohistochemical, in lieu of immunoblotting, procedures to
localize neuronal transduction within the NAC shell versus core.
For this, animals were euthanized with an overdose of Euthasol
(Virbac AH, Fort Worth, TX, USA) and transcardially perfused
with phosphate-buffered saline (PBS), followed by 4%
paraformaldehyde. Brains were then removed and cold-stored
in PBS until slicing. Tissue was sectioned (40 µm) along the
coronal plane on a vibratome at the level of the NAC. As in our
recent work (8), localization of the transfection of neurons by our
shRNA-Homer2b, as well as by our GFP control viruses, was
examined using an anti-GFP antibody (Invitrogen, Carlsbad, CA,
USA; 1:200 dilution) and fluorescence microscopy. As in our
prior work (8, 25, 26), tissue from cDNA-Homer2b infused mice
was stained with a mouse antihemagglutinin (HA) primary
antibody (Biolegend, San Diego, CA, USA; 1:1,000 dilution) to
visualize the viral construct, followed by a biotinylated
antimouse secondary IgG (Vector Laboratories, Burlingame,
CA, USA; 1:2,000 dilution), and visualized with 3,3’-
diaminobenzidine (DAB). Poststaining, all tissue was mounted
on slides and cover-slipped. Slides were viewed using a Nikon
Eclipse E800 microscope equipped with a Hamamatsu CCD
camera (model C4742-95) and MetaMorph imaging software
(Molecular Devices, Sunnyvale, CA, USA). Only mice exhibiting
localized neuronal transduction within the NAC shell and core
subregions were included in the statistical analyses of the results.Statistical Approaches
The effects of Homer2b knockdown in the NAC core upon place-
conditioning related measures were analyzed using t-tests. The
operant-conditioning data were analyzed using multivariate
ANOVAs, with the between subjects factors of Sex and AAV
(GFP vs. shRNA or GFP vs. cDNA) and/or Genotype (WT vs.
Homer2 KO) and the within-subjects factors of Day, FR
schedule, and Dose, when appropriate. As initial analyses of
the data for both place- and operant-conditioning in Homer2
WT and KO mice indicated no main Sex effects or interactions,
the data were collapsed across sex prior to reanalyses. As
described above, the data for Homer2 WT/KO mice tested for
the self-administration of 80 mg/L MA were analyzed separately
using t-tests. Two-tailed Pearson correlational analyses were also
conducted to relate dependent measures with CPP score. a =
0.05 for these analyses. The effects of Homer2 KO on the dose-
response function for MA-induced place-conditioning were
analyzed using ANOVAs, with the between-subjects factors of
Genotype (WT vs. KO) and Dose (0.5–4.0 mg/kg MA, 4 levels).
All data was analyzed using SPSS ver 12 (IBM) and for all
ANOVAs, the homogeneity of variance was confirmed. Alpha
was set at 0.05 for all analyses.February 2020 | Volume 11 | Article 11
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Homer2 Knockdown in the NAC Core
Augments a MA CPP in B6 Mice
To extend recent results for the NAC shell (8) to the core
subregion, B6 mice were infused with an AAV carrying
shRNA to knockdown Homer2b in the NAC core and then
tested for MA-induced CPP. Expression of the AAV was
confirmed as confined to the NAC core using fluorescence
microscopy (Figures 1B, B’). shRNA-infused mice exhibited
higher CPP following four pairings of 2 mg/kg MA than GFP-
infused controls (Figure 1C) [t(30) = 2.14, p = 0.04]. The
shRNA-Homer2b NAC core infusion did not affect the acute
locomotor response to MA [data not shown; t(30) = 0.39, p =
0.70], nor did it alter the magnitude of MA-induced locomotorFrontiers in Psychiatry | www.frontiersin.org 6sensitization that developed over the course of the conditioning
(Figure 1D) [t(30) = 0.47, p = 0.64]. These data indicate that
Homer2 within the NAC core normally suppresses the positive
affective and motivational valence of MA, independent of effects
upon without interfering with the locomotor-activating effects of
the drug.
Homer2 Knockdown in the NAC Core
Augments Oral MA Reinforcement Intake
in B6 Mice
During the first 5 days of self-administration training under an
FR1 reinforcement schedule, both GFP and shRNA animals
exhibited a similar pattern of active nose-pokes (Figure 2A)
[Day effect: F(1,29) = 28.33, p < 0.0001; AAV effect, interaction:
p’s > 0.10], ratio of active vs. inactive responding (Figure 2B)FIGURE 2 | Homer2b knockdown in the nucleus accumbens (NAC) core increases methamphetamine’s (MA’s) reinforcing efficacy without altering MA intake.
shRNA against Homer2 did not influence: (A) the number of active nose pokes, (B) the relative responding on the active versus inactive hole or (C) MA intake during
the first 5 days of self-administration training (10 mg/L MA as reinforcer). (D–F) shRNA infusion also did not alter these measures when mice were tested under
increasing response requirements on an FR schedule of reinforcement. (G) shRNA infusion shifted the dose-response function for active hole poking upwards of
green fluorescent protein (GFP) controls but did not affect the dose-response functions for (H) response allocation or (I) MA intake. The data represent the means ±
SEMs of the number of mice indicated in Panel A. *p < 0.05 vs. GFP [main adeno-associated viral vector (AAV) effect].February 2020 | Volume 11 | Article 11
Brown et al. Homer2 and Methampehtamine[Day effect: F(1,29) = 2.56, p = 0.04; AAV effect and interaction,
p’s > 0.20], and MA intake (Figure 2C) [Day effect: F(1, 29) =
12.20, p = 0.002; AAV effect, interaction: p’s > 0.10]. When tested
under increasing response requirements, responding on the
active lever increased (Figure 2D) [FR effect: F(1,29) = 76.00,
p < 0.0001], the ratio of active vs. inactive responding increased
(Figure 2E) [FR effect: F(1,29) = 25.32, p < 0.0001], and MA
intake decreased (Figure 2F) [FR effect: F(1,29) = 20.17, p <
0.0001], but there was no effect of Homer2b knockdown on any
of these measures (Figures 2D–F; AAV effects and interactions,
all p’s > 0.20). Thus, Homer2 within the NAC core is not
necessary for the acquisition of oral MA self-administration or
MA demand, at least when behavior is reinforced by a low, 10
mg/L MA concentration.
In contrast, Homer2b knockdown in the NAC core shifted
upwards the dose-response function for active nose-poking
behavior (Figure 2G) [AAV effect: F(1,29) = 5.31, p = 0.03;
Dose effect: F(1,29) = 4.65, p = 0.002; interaction, p = 0.799],
without impacting the ratio of active vs. inactive responding
(Figure 2H; AAV X Dose ANOVA, p’s > 0.35), or the dose-
response function for MA intake (Figure 2I) [Dose effect: F
(1,29) = 77.35, p < 0.0001; AAV effect, interaction, p’s > 0.30].
These data indicate that Homer2 within the NAC core normally
curbs the reinforcing efficacy of MA in mice with a history of
self-administration, but this effect does not translate into a
change in MA intake.
Constitutive Homer2 KO Increases
Ma-Induced CPP
The results of our shRNA study above indicate that Homer2
within the NAC core normally suppresses behavioral indices of
MA reward and reinforcement, which is a finding opposite to
that reported for Homer2 in the NAC shell (8). Thus, we
employed a complementary AAV-cDNA strategy (25, 26, 29)
in WT littermates and Homer2 KO mice to determine whether
Homer2 in the NAC shell promotes, while that in the core
suppresses, MA place- and operant-conditioning. We know that
Homer2 KO mice exhibit greater sensitivity to the psychomotor-Frontiers in Psychiatry | www.frontiersin.org 7activating effects of MA (36); however, their MA reward/
reinforcement phenotype has yet to be characterized.
Therefore, we first assayed the effects of a constitutive Homer2
KO on MA place- and operant-conditioning. A genotypic
comparison of the dose-response function for the time spent in
the MA-paired vs. -unpaired side during the post-test phase of
place-conditioning indicated greater MA-induced CPP,
irrespective of MA dose (Figure 3A) [Genotype effect: F(1,
86) = 14.83, p < 0.0001; Genotype X Dose: F(3, 86) = 2.54, p =
0.06], although the genotypic difference in MA-conditioned
behavior was most obvious at lower MA concentrations.
Despite exhibiting potentiated MA-conditioned reward,
Homer2 KO mice did not differ significantly from WT
littermate controls regarding the acute locomotor stimulatory
effects of MA during the first conditioning session (Figure 3B)
(Genotype X Dose ANOVA, all p’s > 0.14) or in the capacity of
the four MA injections to elicit a dose-dependent sensitization of
locomotion during the conditioning phase of the study, as
determined by the difference in the distance traveled from the
first to the forth injection (Figure 3C) [Dose effect: F(1,79) =
8.00, p < 0.0001; Injection: F(3,237) = 8.94, p < 0.0001; Dose X
Injection: F(9,237) = 2.47, p = 0.01; Genotype X Dose: F(3,79) =
2.23, p = 0.09; all other p’s > 0.30]. While this result contradicts
our earlier report, these conditioning sessions were only 15-min
long, while in Szumlinski et al. (36), the sessions were 1 h so the
di fference in durat ion of tes t ing l ike ly mit iga ted
genotypic differences.
Constitutive Homer2 KO Increases MA-
Reinforcement and Intake
The number of active hole pokes emitted by KO mice
progressively increased across training days, whereas the
responding of WT mice fluctuated during early training
(Figure 4A) [Genotype X Day: F(4, 140) = 5.71, p < 0.0001].
Post hoc analyses indicated greater active hole responding in KO
versus WT mice on day 2, 3, and 5 of training (Figure 4A; t-tests,
p’s < 0.03). No genotypic differences were observed for the
number of inactive hole pokes (data not shown; Genotype XFIGURE 3 | Constitutive Homer2 deletion augments a methamphetamine (MA)-induced conditioned place-preference (CPP). When compared to wild-type (WT)
mice, Homer2 knockout (KO) animals exhibited (A) a shift upwards in the dose-response function for a MA-induced CPP. In contrast, gene deletion did not alter the
dose-response functions for (B) acute MA-induced locomotor activity or (C) the increase in locomotor activity from the first to the last MA-conditioning session
(sensitization). The data represent the means ± SEMs of the number of mice indicated in Panel A. *p < 0.05 vs. WT (main Genotype effect).February 2020 | Volume 11 | Article 11
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active vs. inactive responding than WT mice during early
training (Figure 4B) [Genotype X Day, F(4,140) = 3.59, p =
0.008], with post-tests indicating significantly lower relative
responding on Days 3 and 5 of training (t-tests, p’s < 0.04).
Despite the lower active nose-poke responding in KO, only the
KO mice escalated their MA intake during early training
(Figure 4C) [Genotype X Day: F(4, 140) = 5.98, p < 0.0001].
WhileHomer2 KOs exhibited significantly lower MA intake than
WT animals on the first training day [t(35) = 2.05, p = 0.05], their
MA intake was significantly higher than WT animals by the 5th
training day [t(35) = 3.18, p = 0.003]. Thus, constitutive Homer2
deletion increases low-concentration MA reinforcement and
intake during early training in a manner similar to shRNA-
mediated knockdown of Homer2b expression within the
NAC core.Frontiers in Psychiatry | www.frontiersin.org 8When the response requirement for reinforcement by 10 mg/L
MA progressively increased across days, KO mice exhibited more
active hole responding, overall, than WT mice (Figure 4D)
[Genotype effect: F(1,35) = 5.27, p = 0.03; interaction: p > 0.6].
The number of inactive hole pokes declined with increasing
response requirement (data not shown) [Schedule effect: F(2,70) =
15.85, p < 0.0001] but was not influenced by genotype (all p’s >
0.60). In contrast to the early acquisition phase (Figure 4B), KO
mice exhibited slightly higher active hole response allocation than
WTmice during this phase of testing (Figure 4D) [Genotype effect:
F(2,70) = 3.63, p = 0.07; Day effect and interaction, p’s > 0.15]. The
MA intake of KOmice was also slightly higher thanWT controls as
response requirement increased (Figure 4E) [Genotype effect: F
(1,35) = 3.26, p = 0.08; FR effect: F(2,70) = 43.48, p < 0.0001;
interaction: p = 0.68]. These data provide some limited evidenceFIGURE 4 | Constitutive Homer2 deletion increases methamphetamine (MA) reinforcement and intake. When compared to WT mice, Homer2 knockout (KO) mice
exhibited a greater: (A) the number of active nose pokes, (B) relative responding on the active versus inactive hole and (C) MA intake during the first 5 days of self-
administration training (10 mg/L MA as reinforcer). (D) Homer2 KO mice also exhibited more active hole responding under increasing response requirement but did not
differ from WT mice regarding (E) response allocation or (F) MA intake during this phase of testing. Relative to WT mice, the dose-response function for active hole-
responding was shifted upwards (G), without a change in that for response allocation in the active hole (H). (I) KO mice also consumed more MA than wild-type (WT)
mice across the range of doses tested. The data represent the means ± SEMs of the number of mice indicated in Panel A. *p < 0.05 vs. WT (main Genotype effect).February 2020 | Volume 11 | Article 11
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concentration MA solution.
The dose-response function (5–40 mg/L MA) for active hole
pokes under the original FR1 schedule of reinforcement was shifted
upward in KO mice, compared to WT mice [Genotype effect: F
(1,35) = 5.57, p = 0.02; interaction, p > 0.10], an effect especially
apparent at lower MA doses (Figure 4F). KO mice also tended to
exhibit higher active hole responding for the 80 mg/L solution (t-
test, p = 0.09). Inactive hole pokes declined as a function of MA
concentration, but no genotypic differences were detected (data not
shown) [5–40 mg/L MA: Dose effect: F(2,70) = 4.19, p = 0.02;
Genotype effect and interactions, p’s > 0.40; 80 mg/L: t-test, p =
0.25]. KO mice continued to show modestly higher relative
responding on the active versus inactive lever during dose-
response testing, but genotypic differences were not statistically
significant (Figure 4H; 5–40 mg/L: Genotype X FR ANOVA, p’ >
0.10; at 80 mg/L, WT vs. KO: t-test, p = 0.06). Finally, in contrast to
Homer2 knockdown (Figure 2I), the MA dose-intake function was
shifted upwards in KO versus WT mice (Figure 4I) [5–40 mg/L:
Genotype effect: F(1,35) = 4.70, p = 0.04; Dose effect: F(2,70) =
50.73, p < 0.0001; Genotype X Dose: p = 0.17; 80 mg/L: t(22) = 2.16,
p = 0.04]. These latter data indicate that the potentiation of MA
reinforcement and intake by constitutive Homer2 deletion extends
across a relatively broad dose-range.
Homer2b Overexpression in the NAC Core,
But Not Shell, Augments a MA-Induced
CPP
The final series of experiments examined the effects of Homer2b
overexpression within the NAC core and shell of Homer2 WT
and KO mice upon MA-induced place- and operant-
conditioning. Immunohistochemical staining for the HA-tag
indicated neuronal transduction within the NAC core (Figure
5B) that was comparable to that observed in prior reports from
our group (e.g., 25, 28). Intriguingly, similar to NAC core
knockdown of Homer2b (Figure 1C) and constitutive Homer2
deletion (Figure 3A), Homer2b overexpression within the NAC
core also potentiated the magnitude of a CPP induced by the
repeated pairing of 2 mg/kg MA (Figure 5D) [AAV effect: F
(1,33) = 7.18, p = 0.01]. While the initial dose-response study
failed to support genotypic differences in the magnitude of the
conditioned response elicited by pairing with 2 mg/kg MA
(Figure 3A), the CPP elicited by this dose in the cDNA study
was lower overall in KO versus WT mice (Figure 5D) [Genotype
effect: F(1,33) = 6.20, p = 0.02; interaction: p = 0.74]. Homer2b
overexpression within the NAC core did not influence the acute
locomotor-response to 2 mg/kg MA (Figure 5E; Genotype X
AAV ANOVA, p’s > 045) nor did it influence the sensitization of
this response during conditioning (Figure 5F; Genotype X AAV
ANOVA, p’s > 0.20). Thus, curiously, overexpressing Homer2b
within the NAC core produces an effect on MA-conditioned
reward akin to that observed upon either constitutive gene
deletion (Figure 3A) or protein knockdown within this region
(Figure 1C).
Immunohistochemical staining indicated robust neuronal
transfection within the NAC shell, with no overt signs ofFrontiers in Psychiatry | www.frontiersin.org 9infection or tissue damage (Figure 5C). Thus, we were
surprised that the level of MA-induced place-conditioning was
lower overall in the mice infused with GFP/cDNA into the NAC
shell (Figure 5G), than that observed for the other place-
conditioning experiments in this report. This low level of
conditioning may have precluded our ability to detect group
differences in the MA-conditioned response (Genotype X AAV,
all p’s > 0.15). Despite lower CPP Scores, the locomotor response
to an acute injection of 2 mg/kg MA was comparable to that
observed in the other studies herein and was not affected by either
Homer2 deletion or intra-shell cDNA infusion (Figure 5H;
Genotype X AAV ANOVA, all p’s > 0.07). Although intra-NAC
shell cDNA infusion appeared to augment the difference in MA-
induced locomotor activity observed from the first to the forth
conditioning session (sensitization), this effect was not statistically
significant (Figure 5I; Genotype X AAV ANOVA, all p’s > 0.06).
These data do not support an active role for Homer2b within the
NAC shell in gating MA-induced locomotion or -conditioned
reward under place-conditioning procedures.
Homer2b Overexpression Within
NAC Subregions Does Not Influence
the Acquisition of Oral MA
Self-Administration
Based on the above results, we predicted that the effects of
Homer2b overexpression upon place-conditioning would
translate to operant-conditioning procedures. However, we
found that Homer2b-cDNA infusion into either the NAC core
(Figures 6A–C) or shell (Figures 6D–F) had no significant effect
on any measure during the first 5 days of training under operant-
conditioning procedures. A significant Genotype X Day
interaction was detected for active hole responding in mice
infused intra-NAC core (Figure 6A) [F(4,120) = 2.83, p =
0.03] that reflected a differential time-course of acquisition
between WT and KO mice as post hoc comparisons between
WT and KO mice failed to indicate genotypic differences in
responding on any training day (t-tests, p’s > 0.15). In neither
genotype did NAC core Homer2b overexpression alter active
hole responding during the first 5 days of self-administration
training (AAV effect and interactions, p’s > 0.20). In mice infused
intra-NAC core, response allocation increased progressively
during early training (Figure 6B) [Day effect: F(4,120) = 4.2,
p = 0.003] and KO mice exhibited overall greater MA-
appropriate responding than WT mice during this phase of
study [Genotype effect: F(1,30) = 4.34, p = 0.05]. However, this
measure was not altered by Homer2b overexpression within the
NAC core (no AAV effect or interactions, p’s > 0.10). Finally, KO
mice tended to consume more MA during the first 5 days of
training (Figure 6C; Genotype X Day: p = 0.09), but there was no
effect of intra-NAC core infusion of Homer2b cDNA upon MA
intake during early training (AAV effect and interactions, p’s >
0.25). Taken together, these data do not support an effect of
Homer2b overexpression within the NAC core in regulating
initial MA reinforcement or intake.
Initial active hole responding was lower in mice infused with
Homer2b-cDNA into the NAC shell than that typically observedFebruary 2020 | Volume 11 | Article 11
Brown et al. Homer2 and Methampehtamineunder our oral MA operant-conditioning procedures
(Figure 6D) and the Genotype X Day interaction failed to
reach statistical significance [Day effect: F(4,128) = 4.79, p =
0.001; Genotype X Day, p = 0.095]. However, as observed for the
NAC core, intra-NAC shell cDNA infusion did not alter activeFrontiers in Psychiatry | www.frontiersin.org 10hole responding (AAV effect and interactions, p’s > 0.22). In
mice infused intra-NAC shell, response allocation progressively
increased across day, irrespective of the genotype or AAV
treatment (Figure 6E) [Day effect: F(4,128) = 8.80, p < 0.0001;
no interactions with the Day factor, p’s > 0.25]. However, inFIGURE 5 | Homer2b overexpression in the nucleus accumbens (NAC) core, but not NAC shell, potentiates a methamphetamine (MA)-induced conditioned place-
preference (CPP). (A) The procedural time-line for the study examining the effects of cDNA-mediated overexpression of Homer2b within the NAC core and shell.
Representative micrographs of the neuronal transduction within the NAC core (B) and NAC shell (C) by antihemagglutinin (HA)-tagged adeno-associated viral vector
(AAV)-cDNA encoding Homer2b (images at 20 X magnification). AC, anterior commissure. (D) The magnitude of a MA-induced CPP was lower in Homer2 knockout
(KO) mice versus wild-type (WT) controls and cDNA infusion into the NAC core potentiated MA-induced place conditioning in both genotypes, without affecting the
(E) acute or (F) sensitized locomotor response to MA. No genotypic difference or cDNA effect were apparent for (G) MA-induced CPP, (H) the acute locomotor
response to MA or (I) the magnitude of MA-induced locomotor sensitization, when the cDNA was infused into the NAC shell. The data represent the means ± SEMs
of the number of mice indicated in Panel C for NAC core and Panel F for NAC shell. *p < 0.05 vs. WT; +p < 0.05 vs. GFP.February 2020 | Volume 11 | Article 11
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Genotype X AAV interaction was detected for the ratio of active
to inactive hole pokes exhibited by mice infused with AAV into
the NAC shell (Figure 6E) [Genotype X AAV: F(1,32) = 5.0, p =
0.03]. Averaging across the 5 training days, this interaction reflected
a cDNA-induced reduction in the response ratio in WT mice [t
(16) = 3.29, p = 0.005], but no effect in KO animals (t-test, p = 0.83).
Finally, MA intake fluctuated during early training in the mice
infused intra-NAC shell (Figure 6F) [Day effect: F(4,128) = 8.08, p <
0.0001]. However, we detected no effect of gene deletion or intra-
NAC shell cDNA infusion during the early training period
(Genotype X AAV X Dose ANOVA, other p’s > 0.25).
Homer2b Overexpression Within the NAC
Shell Reduces the Efficacy of Oral MA to
Serve as a Positive Reinforcer
Homer2b-cDNA infusion into the NAC core (Figures 7A–C)
did not influence any self-administration measure as a function
of the concentration of the MA reinforcer. The dose-response
function for active hole-poking was relatively flat in mice infused
intra-NAC core with our AAVs and there was no effect of
Homer2 deletion or AAV infusion upon this measure (Figure
7A; Genotype X Dose X AAV ANOVA, all p’s > 0.12). AlthoughFrontiers in Psychiatry | www.frontiersin.org 11KO mice tended to exhibit a higher ratio of active versus inactive
responding during dose-response testing (Genotype effect, p =
0.07), no significant group differences were detected for this
measure at any MA dose tested (Figure 7B; Genotype X Dose X
AAV ANOVA, other p’s > 0.15). In this experiment, Homer2
deletion shifted the dose-response for MA intake (Figure 7C)
[Genotype X Dose: F(4,120) = 3.04, p = 0.02], but post hoc tests
failed to confirm genotypic differences at any MA dose (t-tests,
p’s > 0.07) and no AAV effects or interactions were detected (p’s
> 0.40). Taken together, these cDNA data argue against an active
role for Homer2b within the NAC core in regulating MA intake
or sensitivity to its reinforcing effects.
In contrast to the NAC core, Homer2b-cDNA infusion into
the NAC shell altered the dose-response function for active nose-
poking behavior (Figure 7D) [AAV X Dose: F(4,120) = 2.89, p =
0.03]. Although inspection of Figure 7D suggested that this
interaction was driven by the results from the WT mice, there
was no genotype effect or interactions with the genotype factor
(Genotype effect: p = 0.10; all interactions with Genotype factor:
p’s > 0.40). Collapsing the data across genotype, post hoc analyses
did not indicate any significant GFP-cDNA difference at any of
the MA concentrations tested (p’s > 0.25), arguing that the AAV
XDose interaction reflected thedistinct shapesof thedose-responseFIGURE 6 | Homer2b overexpression does not alter methamphetamine (MA) reinforcement and intake during early training for MA self-administration. When
compared to WT (left) and Homer2 knockout (KO) (right) mice infused with green fluorescent protein (GFP), cDNA infusion into the nucleus accumbens (NAC) core
did not alter: (A) active hole responding, (B) response allocation or (C) MA intake during the first 5 days of self-administration training. (D–F) Similarly, cDNA infusion
into the NAC shell did not affect any measure of self-administration during early training. The data represent the means ± SEMs of the number of mice indicated in
Panel A (NAC core) and Panel D (NAC shell).February 2020 | Volume 11 | Article 11
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descending). Homer2b-cDNA into the NAC shell also altered the
dose-response function for the ratio of active versus inactive
responding (Figure 7E) [AAV X Dose: F(4,120) = 2.89, p = 0.03]
- an effect driven by the shift down-wards in the dose-response
response produced by cDNA infusion in the WT mice (Figure 7E)
[GenotypeXAAV: F(1,30) = 4.20, p = 0.05].While it appeared that an
intra-NAC shell infusion of Homer2b-cDNA lowered MA intake
selectively in WT mice (Figure 7F), no group differences were
observed with respect to the MA dose-intake function [Dose effect: F
(1,124) = 12.73, p < 0.0001; all other p’s > 0.40]. Taken together, these
data argue that Homer2b overexpression within the NAC shell lowers
the efficacy of MA to serve as a reinforcer, without significantly
impacting MA intake.Homer2b Overexpression Within NAC
Subregions Does Not Alter the Extinction
or Reinstatement of MA-Seeking
Although Homer2b-cDNA infusion into the NAC core appeared
to reduce the number of trials to reach extinction criterion in
both WT and KO mice (Figure 8A), no group differences wereFrontiers in Psychiatry | www.frontiersin.org 12detected for this measure (Genotype X AAV ANOVA, p’s >
0.09). Likewise, neither Homer2 deletion nor Homer2b-cDNA
infusion into the NAC shell altered the time taken to extinguish
responding in the active hole (Figure 8B; Genotype X AAV
ANOVA, p’s > 0.31). A comparison of active hole responding
during the last day of extinction with that elicited by presentation
of the MA-associated cue or a priming injection of 1 or 2 mg/kg
MA indicated greater responding, overall, in Homer2 KO versus
WT mice, irrespective of the AAV infused into the NAC core
(Figure 8C) [Test effect: F(3,81) = 6.31, p = 0.001; Genotype
effect: F(1,27) = 5,26, p = 0.03; no AAV effect and no interactions,
p’s > 0.25]. Inspection of Figure 8C suggested that cDNA into
the NAC core differentially affected the magnitude of cue-
induced reinstatement (0 mg/kg MA), while exerting no effect
on MA-primed responding. However, a direct comparison of
responding on the cued reinstatement test and the extinction
baseline failed to detect any interaction with the AAV factor
[AAV effect and interactions, p’s > 0.30; Genotype X Test: F
(1,28) = 5.91, p = 0.02]. Akin to the findings for the NAC core,
cDNA infusion into the NAC shell also did not significantly
influence active hole responding during the tests for
reinstatement of drug-seeking (Figure 8D; no AAV effect orFIGURE 7 | Homer2b overexpression in the nucleus accumbens (NAC) shell blunts methamphetamine (MA) reinforcement only in wild-type (WT) mice. When
compared to WT (left) and Homer2 knockout (KO) (right) mice infused with green fluorescent protein (GFP), cDNA infusion into the NAC core did not alter the dose-
response functions for: (A) active hole responding, (B) response allocation or (C) MA intake. (D) cDNA infusion into the NAC shell caused a declining dose-response
function for active hole-responding in both WT and KO mice, (E) lowered the dose-response function for response allocation in the active hole in WT mice, but (F)
did not significantly alter the dose-response function for MA intake. The data represent the means ± SEMs of the number of mice indicated in Panel A (NAC core)
and Panel D (NAC shell). *p < 0.05, main AAV effect. Main Genotype effects are not indicated for clarity but are described in the text.February 2020 | Volume 11 | Article 11
Brown et al. Homer2 and Methampehtamineinteractions, p’s > 0.17), but again, Homer2 KO mice exhibited
greater responding overall, compared to WT mice [Genotype
effect: F(1,27) = 4.40, p = 0.04]. These data for the extinction and
reinstatement of MA-seeking argue a suppressive role for
Homer2 in regulating behavior but do not support either NAC
subregion as the active loci of these effects.DISCUSSION
Homer2 is a postsynaptic scaffolding protein regulating the
localization and function of glutamate receptors [c.f., (37–44)]
and its expression within the NAC plays a necessary and active
role in behavioral sensitivity to both cocaine and alcohol [c.f.,
(27, 37)]. In more recent work (8), idiopathic, genetic, and MA-
induced vulnerability to MA addiction-related behaviors was
found to be associated with increased indices of glutamate
signaling within the NAC, including elevated Homer2
expression. More specifically, the magnitude of a MA-induced
CPP is highly correlated with Homer2 expression within both
the shell and core subregions of the NAC, arguing a potential role
for Homer2-dependent neuroadaptations within both
subregions in the motivational valence of MA. However, in
both genetically vulnerable MAHDR and MA-sensitized B6Frontiers in Psychiatry | www.frontiersin.org 13mice, increased behavioral sensitivity to MA was associated
with elevated Homer2 expression within the NAC shell only,
suggesting some subregional specificity may exist within the
NAC regarding the relationship between Homer2-dependent
signaling and MA-induced behaviors. Using an shRNA
strategy to selectively knockdown the major rodent isoform of
Homer2 [Homer2b; (45)] within the NAC shell, we
demonstrated previously little to no effect upon the magnitude
of a MA-CPP, but a marked reduction in responding for oral MA
reinforcement and for MA intake when the same mice were
assayed under operant-conditioning procedures. Such data
argued a necessary role for Homer2b within the NAC shell for
MA reinforcement/intake and suggested that idiopathic or MA-
induced increases in NAC shell Homer2b expression promotes a
MA addicted phenotype (8). Herein, we extended the results of
this prior study to the NAC core.
Further, to determine whether Homer2b within either NAC
subregion actively regulates MA-induced changes in behavior,
we also applied our cDNA-Homer2b strategy [e.g., (25, 26, 28,
34)] in bothWT and constitutiveHomer2 KOmice to upregulate
Homer2b expression. The results show that constitutive Homer2
deletion potentiated MA-CPP, oral MA reinforcement/intake
under operant-conditioning procedures, and the reinstatement
of MA-seeking following response extinction. A subset of theseFIGURE 8 | Homer2b overexpression in nucleus accumbens (NAC) subregions does not significantly alter genotypic differences in responding under extinction-
reinstatement procedures. Although it appeared that cDNA infusion into the NAC core reduced the number of trials taken to reach extinction criterion in both wild-
type (WT) and Homer2 knockout (KO) mice, no cDNA effect was observed on this measure when infused into either the NAC core (A) or the NAC shell (B). (C)
Homer2 KO mice exhibited greater cue- and MA-primed reinstatement of active hole responding than WT mice, but NAC core infusion of cDNA did not affect
responding in either WT (0left) or KO animals (right). (D) cDNA infusion into the NAC shell also did not alter the genotypic difference in reinstatement. The data
represent the means ± SEMs of the number of mice indicated in their respective panels. Main Genotype effects are not indicated for clarity but are described in the
text. The sample sizes in this figure are lower than those indicated in Figures 6 and 7 as some animals were euthanized following MA self-administration procedures
due to illness.February 2020 | Volume 11 | Article 11
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NAC core, providing new evidence that Homer2b within the
NAC shell and core oppositely regulate MA reinforcement.
While the present shRNA findings argue a suppressive role for
NAC core Homer2b expression in regulating MA reward/
reinforcement, cDNA-Homer2b infusion within this subregion
also potentiated a MA-CPP, without affecting measures of MA
reinforcement/intake/reinstatement. Opposite our expectations
(8), Homer2b overexpression within the NAC shell reduced
indices of MA reinforcement but did not affect other
behavioral measures. Below, we discuss these effects of
bidirectional manipulations of Homer2b within the NAC in the
context of animal models of MA reward and reinforcement. The
data collected during this study are summarized in Table 1.Constitutive Homer2 Deletion Tends to
Promote MA Reward/Reinforcement
Constitutive Homer2 deletion potentiated: MA-conditioned
reward (Figure 3A), responding for oral MA reinforcement
and MA intake under operant-conditioning procedures
(Figures 4 and 7), and the number of trials required to
extinguish MA-seeking behavior (Figure 8A). Additionally,
Homer2 deletion increased the magnitude of both cue- and
MA-primed reinstatement of MA-seeking behavior following
extinction (Figures 8C, D). Further, the increased MA
reinforcement and intake observed in Homer2 KO mice was
apparent early during self-administration training (Figures 4A–
C) and persisted across a range of MA doses in MA-experienced
mice (Figures 4G–I). Such data argue a suppressive role for
Homer2 in both gating vulnerability to early MA abuse and
maintaining an addicted phenotype. Although genotypic
differences in MA-induced locomotor activity were not
observed in the present study (Figures 3B, C), we reported
previously that the dose-response function for acute MA-
induced locomotor activity is shifted upwards in Homer2 KO
mice versus WT controls (36). Thus, it is possible that the
increased MA reinforcement and intake exhibited by Homer2
KO mice herein relates to the greater efficacy of the drug to
induce psychomotor activation. The precise reason for the
present failure to replicate genotypic differences in MA-
induced locomotion is not entirely clear but likely reflects
procedural differences between the studies. First and foremost,
the two studies were conducted in two distinct research
institutions (Medical University of South Carolina vs.
University of California Santa Barbara); thus a host of
environmental differences may have contributed to the
differential results to include the fact that the mice in the
present study were bred in-house, while those in our earlier
study were obtained from the laboratory of Dr. P.F. Worley at
Johns Hopkins University School of Medicine. Also, the present
experiments employed both a shorter testing period (15 vs. 60
min) and a smaller testing arena than our prior report.
Additionally, mice in the present study underwent saline-
conditioning sessions on the days intervening between MA
injections, while mice in the prior study were injected withFrontiers in Psychiatry | www.frontiersin.org 14MA only (36). Nevertheless, the present data for MA reward/
reinforcement in Homer2 KO mice aligns well with those
reported for cocaine reward/reinforcement (25), providing new
evidence for a generalization of a “proaddictive” phenotype of
Homer2 KO mice across different psychomotor stimulant drugs
of potential relevance for the neurobiology of psychomotor
stimulant abuse liability and/or MA-cocaine coabuse.
Drawbacks of a constitutive KO approach for studying the
neurobiology of behavior relate to the lack of developmental and
neuroanatomical specificity of gene deletion. There exist three
different Homer isoforms, with Homer1 and Homer2 isoforms
expressed in midbrain and forebrain regions highly implicated in
addiction neurobiology (45). Further, distinct Homer1 isoforms
differentially regulate spontaneous and stimulant-induced
changes in behavior (32, 36), with imbalances in the relative
expression of Homer1 versus Homer2 isoforms within mPFC
gating cocaine-conditioned reward (34) and the reinstatement of
cocaine-seeking behavior (46). Although extant correlative
evidence does not support a relationship between Homer1
protein expression within either NAC subregion or within the
mPFC and MA behavioral sensitivity (4, 8), such findings do not
preclude the possibility that compensatory changes in Homer1
expression/function may contribute to the “proaddictive”
phenotype of Homer2 KO mice.
Subregional Selectivity in the Effects of
Homer2b Knock-Down Within NAC Upon
MA Reward/Reinforcement
In brain, Homer2 expression is regulated in a regionally selective
manner by prior MA experience in inbred B6 mice, with
increases in protein expression observed selectively within the
NAC shell (4, 8). Further, increased Homer2 expression within
the NAC shell, but not core, is a biochemical correlate of genetic
vulnerability to consume MA in mice on a heterogeneous genetic
background (8). Providing causal evidence that Homer2
functions to alter MA reward/reinforcement in a subregionally
distinct manner, Homer2b knockdown in the shell reduces (8),
while knockdown in the core increases, both the magnitude of a
MA-CPP and responding for a MA reinforcer (Figures 1 and 2).
Thus, the effects of constitutiveHomer2 deletion uponMA reward/
reinforcement/intake (Figures 3 and 4) are recapitulated, albeit
incompletely, by Homer2b knockdown within the NAC core
(Figures 1 and 2; Table 1). Given the neuroanatomical nature of
our research question, we deemed it more critical to decipher the
site of AAV transductionwithinNAC subregions than quantify the
efficiency of our shRNA construct to alter Homer2b protein
expression. The fact that the phenotype produced by Homer2b
knockdown in the NAC core did not fully recapitulate that of the
Homer2KOmouse is perhapsnot surprising aswe know fromprior
work that our shRNA-Homer2b infusion procedure consistently
reduces protein expression by 40%–50% in vivo (31, 33, 34, 47) and
does not completely eliminate protein expression as is the case for
gene deletion. Further, in humans, MA addiction is associated with
anomalies in the function of many brain structures that were not
targeted herein (48–50). Indeed, lower Homer2 expression within
the mPFC of mice is associated with both genetic and idiopathicFebruary 2020 | Volume 11 | Article 11
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drug under operant-conditioning procedures (4). Thus, it is highly
likely that Homer2 within other structures embedded within
putative addiction neurocircuits functions also to regulate MA-
conditioning,MA-seeking andMA-taking behavior and contribute
to the robust MA phenotype of Homer2 KO mice. Although
Homer2b knock-down in the NAC core does not fully
recapitulate the effect of constitutive gene deletion, it is interesting
to note that the phenotype produced by Homer2b knock-down in
the NAC core predominates in the Homer2 KOmouse (Table 1).
In our limited experience using shRNA to target Homer2
expression within both NAC subregions (29) and to the best of
our knowledge of the extant Homer2 literature, our shRNA-
Homer2 findings for MA reward/reinforcement [(8); present
study] are the first to demonstrate opposing roles for Homer2b
within NAC subregions in regulating addiction-related
behavior. We know through studies of constitutive Homer2
KO mice and of the effects of intracranial shRNA-Homer2b
infusion that intact Homer2 expression is important for:
maintaining basal extracellular glutamate levels within both
the NAC and mPFC (25, 34, 47), cocaine- and alcohol-
stimulated glutamate release (25, 26, 32, 33), and the
expression/function of glutamate receptors, transporters, and
signaling molecules within these regions (25, 26, 34). However,
we are unaware of any study that has directly compared the
effects of either Homer2 deletion or Homer2b knockdown upon
any biochemical measure between NAC subregions to inform
the mechanisms underpinning the opposing MA effects of
Homer2b knockdown observed herein. That being said, we do
know from studies of the mPFC that shRNA-Homer2b (and
cDNA-Homer2b) infusion can produce not only local effects
upon basal and drug-stimulated changes in extracellular
glutamate, in addition to changes in the expression of
Homer2 and glutamate receptor-related proteins, but can also
alter these biochemical measures within NAC, intriguingly in a
direction sometimes opposite that observed at the site of
infusion (34). As striking examples, intra-mPFC infusion of
cDNA-Homer2b elevates basal extracellular glutamate content
and Homer2 expression, in addition to blunting drug-
stimulated glutamate release at the site of infusion, but lowersFrontiers in Psychiatry | www.frontiersin.org 15the glutamate content and expression of both Homer1/2 and
mGlu1/5 and potentiates drug-stimulated glutamate release
within the NAC. Further, intra-mPFC infusion of shRNA-
Homer2b reduces Homer2 and mGlu5 expression at the
infusion site, but elevates markedly the expression of GluN2b,
without affecting extracellular glutamate or the expression of
Homers or mGlu1/5 within the NAC (34). These adaptations
within NAC cannot be readily explained by anterograde
transport of the AAVs and argue that the opposing effects of
shRNA-Homer2b infusion into the NAC shell and core
observed herein could reflect yet uncharacterized distinctions
in local changes in extracellular glutamate and/or glutamate
receptor function/expression that differentially alter the activation
of efferents or could reflect yet uncharacterized biochemical
alterations within those efferent structures (e.g., ventral pallidum).
Inconsistent Effects of Increasing
Homer2b Expression Within the NAC
Shell and Core Upon MA Reward/
Reinforcement
The observed effects of intra-NAC core/shell shRNA-Homer2b
infusion argued that Homer2b expression within the NAC core
suppresses, while that in the NAC shell promotes, certain MA
addiction-related behaviors in mice [Figures 1 and 2; (8)].
However, when this hypothesis was tested directly using well-
established AAV-cDNA approaches that increase local Homer2b
expression by approximately 50% (25, 26, 28, 34, 47), we found
no supporting evidence for either notion. If anything, the results
from our cDNA study were opposite those predicted from our
shRNA experiments. For one, intra-NAC shell infusion of
cDNA-Homer2b lowered the dose-response functions for MA-
reinforced/appropriate responding in WT mice (Figures 5F, 6D,
E)—an effect qualitatively similar to (albeit more robust than)
that observed upon Homer2b knockdown in this subregion of B6
animals (8). Also, an intra-NAC core infusion of either shRNA-
Homer2b in B6 mice or cDNA-Homer2b in B6-129 hybrid WT
mice produced a quantitatively similar increase in the magnitude
of a MA-CPP (Figure 1D vs. Figure 5E). Despite baseline
differences in responding, Homer2b overexpression and
underexpression within NAC core produces similar effects uponTABLE 1 | Summary of the results of the present experiments.
Behavioral Measure Core
Knockdown
Constitutive
KO
Core Over-expres-
sion: Effects of KO
Core Over-expression:
Effects of cDNA
Shell Over-expres-
sion: Effect of KO
Shell Over-expres-
sion: Effect of cDNA
CPP ↑ ↑ ↓ ↑ – –
Locomotor Sensitization – – – – – –
Self-Administration Training – ↑ – – – –
Increasing Response
Requirement
– ↑ N/D N/D N/D N/D
Self-Administration Dose
Response Curve
↑ ↑ – – – ↓
Trials to Extinction N/D N/D – – – –
Cue- & MA-induced
reinstatement of self-
administration
N/D N/D ↑ – –February 2020↑ denotes an increase in behavior relative to control. ↓ denotes a decrease in behavior relative to control. – denotes no effect of manipulation relative to control. N/D denotes not
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within the context of operant-conditioning, in no instance did
cDNA-Homer2 infusion into either NAC subregion significantly
alter, let alone reverse, the MA phenotype of Homer2 KO mice
(Figures 7 and 8).
These null data are in stark contrast to our earlier reports
demonstrating a complete reversal of the behavioral and/or
neurochemical phenotype of Homer2 KO mice by site-directed
infusions of our cDNA-Homer2b construct (25, 26, 34). In only
one instance did the data for cDNA-Homer2b infusion align
with our predictions and this was observed within the context of
extinction/reinstatement procedures. Although the results failed
to reach statistical significance, cDNA-Homer2b infusion into
the NAC core facilitated the extinction of operant-behavior (an
effect observed in both WT and KO mice; Figure 8A) and
blunted the capacity of the MA-associated cues to reinstate
responding in WT mice (Figure 8B). That being said, cDNA-
Homer2b infusion into the NAC shell produced a comparable
reduction of cue-induced reinstatement as that observed in mice
infused intra-NAC core (Figure 8A vs. Figure 8B). Such null
results argue strongly against an active and autonomous role for
Homer2 within either NAC subregion in regulating MA-
conditioned reward or self-administration. Alternatively, these
data could also suggest that any dysregulation in Homer2
expression, be it overexpression or underexpression, is
sufficient to perturb normal glutamate transmission within
NAC subregions to affect MA reward/reinforcement. Which,
and how, specific signal transduction pathways are affected by
increasing versus decreasing Homer2 expression within different
NAC subregions remains to be determined and are important
research questions for future studies aimed at understanding
more precisely the role played by this scaffolding protein in
regulating MA addiction-related behaviors.
Additional Caveats of the Current Study
Table 1 summarizes the major findings from this study, which
are complicated to interpret to say the least. Adding to the
interpretational difficulty is the notable fact that the baseline
behavior of the control animals varied considerable across the
different experiments. For instance, the baseline CPP behavior of
GFP-infused B6 mice in the shRNA study of the NAC core was
approximately half that of the WT B6-129 mice in the cDNA
study of this region (Figure 1C vs. Figure 5D). These
experiments were conducted over a year apart; thus, we cannot
decipher from the current experimental design whether or not
this difference in baseline CPP reflects environmental factors
(e.g., differences in laboratory or animal care personnel) or strain
differences in behavioral sensitivity to MA. Indeed, marked
strain differences are reported between C57BL/6J mice and
DBA2/J mice with respect to MA intake, with C57BL/6J mice
exhibiting significantly lower MA intake than DBA2/J mice [e.g.,
(51–53)]. To date, we have yet to directly compare MA CPP,
reinforcement or intake between B6 mice and mice on a mixed
B6-129 background so we cannot rule out the potential
contribution of background strain to our findings. However,
arguing more in favor of environmental factors as contributors toFrontiers in Psychiatry | www.frontiersin.org 16the differences in baseline CPP, the 2 mg/kg MA dose elicited
negligible CPP in the B6-129 mice infused with cDNA into the
NAC shell (Figure 5G), despite these animals exhibiting similar
acute and sensitized locomotor responses to the drug as those infused
with cDNA into the NAC core (Figures 5E, F vs. Figures 5H, I). The
MA self-administration behavior of the B6-129 mice infused with
cDNA into the NAC shell was also lower than that exhibited by their
NAC core counterparts, particularly during the training phase of the
experiment (Figure 6). Such behavioral differences cannot be
attributable to differences in genetic background.
Further, we would like to be forthcoming and report that,
unfortunately, during the year we were conducting the NAC shell
cDNA study, building renovations were occurring on the level
beneath our laboratory. While arrangements were in place to
minimize the noise and vibration during the daylight hours when
the animals were being tested, we cannot rule out the possibility
that the construction conducted during the evening hours
affected the behavior of the animals nor did we have any
control over, or ability to predict, any construction that took
place during the day. For this very reason, the cDNA study of the
NAC shell was conducted in 3 distinct cohorts of 21–25 B6-129
mice, spaced 1–3 months apart in accordance with the limited
information we were provided regarding heavy construction/
demolition. However, despite our best attempts to avoid this
confound, we were unsuccessful at eliciting a CPP in this
experiment. Indeed, the number of mice exhibiting a
conditioned place-aversion [CPP Score <–100 s; see (8)] in
each cohort of the cDNA study of the NAC shell was higher
than that observed in the cDNA study of the NAC core (shell: 3–
5/cohort vs. core: 2–3/cohort), with more mice exhibiting place-
ambivalence. It is also possible that the AAV-GFP infusion into
the NAC shell might have inadvertently affected the behavior of
the B6-129 mice, although we observed no overt signs of
infection or tissue damage. However, we deem this unlikely as
we have conducted numerous experiments in which this AAV
was infused into the NAC shell, to include studies of MA- (8),
alcohol- (26, 28), and cocaine-induced place-conditioning (25)
and observed no obvious off-target effects of the AAV upon the
expression of the conditioned response. Thus, we surmise that
factors related to building renovations likely confounded data
interpretation from the cDNA study of the NAC shell.
Concluding Remarks and Future Directions
Considerable neuropharmacological, chemogenetic, and
optogenetic work has established that the NAC shell and core
are embedded within distinct neural subcircuits that
differentially contribute to aspects of drug-conditioning, drug-
taking, and drug-seeking behavior, the most well characterized of
which are the relatively dense afferents from, respectively, the
infralimbic (IL) and prelimbic (PL) subregions of the mPFC [e.g.,
(54, 55)]. The majority of data argue that PL-NAC (core)
projections are involved in driving or executing operant
behavior in the context of drug self-administration, whereas
IL-NAC (shell) projections are more critical for suppressing or
inhibiting responding [e.g., (56, 57)]. This being said, there is
overlap in the PL and IL projections to specific NAC subregionsFebruary 2020 | Volume 11 | Article 11
Brown et al. Homer2 and Methampehtamine(55, 58) that can bear on how specific corticoaccumbens
projections might influence responding for drugs and natural
reinforcers [see (54, 59, 60)]. Thus, while the available data
pertaining to Homer2 regulation of MA addiction-related
behavior in mice do not reliably support an active role for
Homer2 within NAC subregions for gating MA addiction-
related behaviors, our AAV findings do not negate a role for
this Homer isoform within NAC afferents, in particular those
from the mPFC, in this regard. Although repeated MA does not alter
Homer2 expression in samples from the entire PFC (to include PL, IL,
and anterior cingulate), reduced PFC Homer2 expression is associated
with both genetic and idiopathic MA addiction vulnerability in mouse
models (4). Given the importance ofmPFC-NAC subcircuits for gating
drug-taking and drug-seeking behavior and based on our earlier
cocaine studies of Homer2 function within mPFC (34), one goal of
future work is to characterize the neuroanatomical selectivity of MA-
induced changes in Homer2/glutamate signaling within PFC
subregions and to interrogate the role played by distinct mPFC-NAC
subcircuits and Homer2 expression within these subcircuits in MA-
taking and MA-seeking behavior.DATA AVAILABILITY STATEMENT
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